These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 24151919)

  • 1. Pharmacokinetics of drugs in mutant Nagase analbuminemic rats and responses to select diuretics.
    Lee JH; Lee YJ; Oh E
    J Pharm Pharmacol; 2014 Jan; 66(1):2-13. PubMed ID: 24151919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of intravenous azosemide in mutant Nagase analbuminemic rats.
    Kim EJ; Lee AK; Kim SH; Kim SG; Lee MG
    Drug Metab Dispos; 2003 Feb; 31(2):194-201. PubMed ID: 12527700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of intravenous trasemide in mutant Nagase analbuminemic rats.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2003 Jan; 24(1):27-35. PubMed ID: 12516076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of intravenous bumetanide in mutant Nagase analbuminemic rats: importance of globulin binding for the pharmacodynamic effects.
    Kim EJ; Lee MG
    Biopharm Drug Dispos; 2001 May; 22(4):147-56. PubMed ID: 11745917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of intravenous methotrexate in mutant Nagase analbuminemic rats.
    Choi YH; Bae SK; Oh JM; Kim SO; Lee MG
    Biopharm Drug Dispos; 2007 Oct; 28(7):385-92. PubMed ID: 17657787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics of drugs in spontaneously or secondary hypertensive rats.
    Yang S; Lee YS; Oh E
    Xenobiotica; 2014 Jan; 44(1):77-88. PubMed ID: 23808362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic changes of drugs in a rat model of liver cirrhosis induced by dimethylnitrosamine, alone and in combination with diabetes mellitus induced by streptozotocin.
    Lee U; Oh E
    Biopharm Drug Dispos; 2015 Jan; 36(1):1-14. PubMed ID: 24861008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Faster clearance of omeprazole in mutant Nagase analbuminemic rats: possible roles of increased protein expression of hepatic CYP1A2 and lower plasma protein binding.
    Lee DY; Jung YS; Kim YC; Kim SY; Lee MG
    Biopharm Drug Dispos; 2009 Apr; 30(3):107-16. PubMed ID: 19288444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus.
    Lee JH; Yang SH; Oh JM; Lee MG
    J Pharm Pharmacol; 2010 Jan; 62(1):1-23. PubMed ID: 20722995
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous theophylline in mutant Nagase analbuminemic rats.
    Kim EJ; Suh OK; Lee MG
    Life Sci; 2003 Jan; 72(11):1231-45. PubMed ID: 12570924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oltipraz in mutant Nagase analbuminemic rats.
    Bae SK; Kang HE; Kang MK; Kim JW; Kim T; Lee MG
    J Pharm Sci; 2006 May; 95(5):998-1005. PubMed ID: 16544321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of water deprivation on drug pharmacokinetics: correlation between drug metabolism and hepatic CYP isozymes.
    Lee JH; Oh JM; Lee MG
    Arch Pharm Res; 2008 Aug; 31(8):951-64. PubMed ID: 18787780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of 5-fluorouracil in mutant Nagase analbuminemic rats: faster metabolism of 5-fluorouracil via CYP1A.
    Choi YH; Bae SK; Kim SO; Lee MG
    Biopharm Drug Dispos; 2007 Mar; 28(2):87-95. PubMed ID: 17230597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum binding and biliary excretion of bilirubin after bilirubin loading in Nagase analbuminemic rats and heterozygous (Jj) Gunn rats.
    Yamashita M; Adachi Y; Kambe A; Nanno T; Nagase S; Yamamoto T
    J Lab Clin Med; 1988 Oct; 112(4):443-9. PubMed ID: 3171353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic alterations in poloxamer 407-induced hyperlipidemic rats.
    Lee U; Kwon MH; Kang HE
    Xenobiotica; 2019 May; 49(5):611-625. PubMed ID: 29658375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of water deprivation for 48 hours on the pharmacokinetics and pharmacodynamics of azosemide in rats.
    Ha HA; Lee SH; Kim SH; Kim ON; Lee MG
    Res Commun Mol Pathol Pharmacol; 1996 Jul; 93(1):109-28. PubMed ID: 8865375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Faster non-renal clearance of metoprolol in streptozotocin-induced diabetes mellitus rats.
    Lee U; Lee I; Lee BK; Kang HE
    Eur J Pharm Sci; 2013 Nov; 50(3-4):447-53. PubMed ID: 23985694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced clearance of ε-acetamidocaproic acid in rats with acute renal failure induced by uranyl nitrate.
    Han SY; Yang SH; Yoon I; Lee MG; Choi YH
    J Pharm Pharmacol; 2012 Oct; 64(10):1452-60. PubMed ID: 22943176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bucolome, a potent binding inhibitor for furosemide, alters the pharmacokinetics and diuretic effect of furosemide: potential for use of bucolome to restore diuretic response in nephrotic syndrome.
    Takamura N; Maruyama T; Chosa E; Kawai K; Tsutsumi Y; Uryu Y; Yamasaki K; Deguchi T; Otagiri M
    Drug Metab Dispos; 2005 Apr; 33(4):596-602. PubMed ID: 15640375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of human drug clearance by multiple metabolic pathways: integration of hepatic and intestinal microsomal and cytosolic data.
    Cubitt HE; Houston JB; Galetin A
    Drug Metab Dispos; 2011 May; 39(5):864-73. PubMed ID: 21303923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.